Luc Panetta, MD1; Catherine Proulx, MD2; Oliver Drouin, MDCM, MSc, MPH2; Julie Autmizguine, MD, MSc1,3; Thuy M. Luu, MD, MSc2; Caroline Quach, MD, MSc1; Fatima Kakkar, MD, MPH1
Introduction
With more than 40 million cases of confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection worldwide, the clinical presentation and risk factors for disease severity among adults and children have now been well described.1 SARS-CoV-2 is the virus that causes coronavirus disease 2019. However, little remains known about disease manifestation and severity of illness in infants.2 Although infants are at higher risk of severe disease and complications from other common viral respiratory pathogens (influenza, respiratory syncytial virus), it is not yet clear whether this is the case with SARS-CoV-2 infection because few series describing outcomes in infants have been published.3,4 The objective of this study was to describe the manifestations and severity of disease among infants with SARS-CoV-2 infection.